Introduction: Pre-eclampsia is a major cause of maternal and prenatal morbidity and mortality, that complicates 2% to 8% of pregnancies worldwide. The aim of this study was to determine the predictive factors for pre-eclampsia in two hospitals in the city of Yaoundé. Methods: A case-control study was conducted at the Gynaecology & Obstetrics department of the Yaoundé Gynaeco-Obstetric and Paediatric Hospital (YGOPH) and the Main Maternity of the Yaoundé Central Hospital (MM-YCH) from February 1 to July 30, 2022. The cases were all pregnant women presenting with pre-eclampsia. The control group included pregnant women without pre-eclampsia. Descriptive statistics followed by logistic regression analyses were conducted with level of significance set at p-value < 0.05. Data were analysed using Epi info version 7.2.5.0 and SPSS version 23.0 software. Results: Included in the study were 33 cases and 132 controls, giving a total of 165 participants. The predictive factors for pre-eclampsia after multivariate analysis were: primiparity (aOR = 51.86, 95% CI: 3.01 - 1230.96, p = 0.045), duration of exposure to partner’s sperm < 3 months (aOR = 23.49, 95% CI: 1.04 - 532.01, p = 0.009), personal history of pre-eclampsia (aOR = 50.36, 95% CI: 2.06 - 1229.92, p = 0.007), and maternal history of pre-eclampsia (aOR = 6.73, 95% CI: 1.68 - 66.65, p = 0.006). Conclusion: The odds of pre-eclampsia increased with primiparity, duration of exposure to partner’s sperm < 3 months, personal history of pre-eclampsia and maternal history of pre-eclampsia. Recognition of these predictor factors would improve the ability to diagnose and monitor women likely to develop pre-eclampsia before the onset of disease for timely interventions.
References
[1]
SFAR CNGOF (2020) Recommandations formalisées d’experts. Prise en charge de la patiente avec prééclampsie sévère. https://gynerisq.fr/wp-content/uploads/2021/05/2020_SFAR_CNGOF_Recos_-preeclampsie_severe
[2]
Leeners, B., Rath, W., Kuse, S. and Lee, C.J. (2006) New Aspects of a Classical Risk Factor for Hypertensive Disorders in Pregnancy. Clinical Research, 111, 81-86. https://doi.org/10.1042/CS20060015
[3]
WHO (1988) International Collaborative Study of Hypertensive Disorders of Pregnancy. Geographic Variation in the Incidence of Hypertension in Pregnancy. American Journal of Obstetrics and Gynecology, 158, 80-83. https://doi.org/10.1016/0002-9378(88)90782-X
[4]
Lansac, J., Beger, C. and Magnin, G. (1990) HTA et grossesse pour le praticien. 2e édition, Masson, Paris, 192-197.
[5]
Toure, I., Brah, F. and Prual, A. (1997) Hypertension artérielle et grossesse au Niger , étude cas/témoins à propos de 70 cas. Medecine d’Afrique Noire, 4, 44-48.
[6]
Bah, A., Diallo, M., Diallo, A. and Keita, N. (2000) Hypertension artérielle et grossesse, aspect épidémiologique et facteurs de risque. Medecine d’Afrique Noire, 47, 422-500.
[7]
Faye, A., Picau, A., Ogowet-Igumu, N., Nlome, N. and Nicolas, P. (1991) L’éclampsie au Centre hospitalier de Libreville 53 cas pour 41 285 accouchements de 1985 à 1989. Revue française de Gynécologie et d’obstétrique, 86, 503-510.
[8]
Leke, R. (1987) Outcome of Delivery at Central Maternity Yaounde.Annales Universitaires des Sciences de la Santé, 4, 322-330.
[9]
Leke, R., Doh, A., Minkande, Z., Mboudou, E., Beyiha, G. and Messi, J. (2009) Evalauation de la prise en charge de la prééclampsie sévère en réanimation, cas de l’Hôpital Gynéco-Obstétrique et Pédiatrique de Yaoundé. Thèse de doctorat en medicine, Université de Yaoundé I, Yaoundé, 8-54.
[10]
Essome, H., Mve Koh, V., Foumane, P., Ekono, M., Boten, M. and Tocki, T. (2019) Prééclampsie à l’Hôpital Laquintinie de Douala, enquête de prévalence et de morbidité de 2010 à 2015. Health Sciences and Disease, 5, 1-5.
[11]
Mboudou, E., Foumane, P., Priso, E., Dohbit, J., Minkande, J., Nkengafac, W., et al. (2009) Hypertension au cours de la grossesse, Aspects cliniques et épidémiologiques à l’Hôpital Gynéco-Obstétrique et Pédiatrique de Yaoundé, Cameroun. Clinics in Mother and Child Health, 6, 1-7. https://doi.org/10.4303/cmch/C101967
[12]
Foumane, P., Dohbit, J., Meka, E., Nkada, M., Minkande, J. and Mboudou, E. (2015) Etiologies de la mortalité maternelle à l’Hôpital Gynéco-Obstétrique et Pédiatrique de Yaoundé, une série de 58 décès. Health Sciences and Disease, 15, 1-7
[13]
Genest, D., Falcao, S., Gutkowska, J. and Lavoie, J. (2012) Impact of Exercise Training on Preeclampsia, Potential Preventive Mechanisms. Hypertens Dallas Tex, 60, 1104-1109. https://doi.org/10.1161/HYPERTENSIONAHA.112.194050
[14]
Saftlas, A., Hsia, J. and Atrash, H. (2002) Principales Complications, Hypertension artéRielle. Journal of Gynecology Obstetrics and Human Reproduction, 31, S28-32.
[15]
Wheeler, T., Elcock, C. and Anthony, F. (1995) Angiogenesis and the Placental Environment. Placenta, 16, 289-296. https://doi.org/10.1016/0143-4004(95)90115-9
[16]
Binder, J., Kalafat, E., Palmrich, P., Pateisky, P. and Khalil, A. (2021) Angiogenic Markers and Their Longitudinal Change for Predicting Adverse Outcomes in Pregnant Women with Chronic Hypertension. American Journal of Obstetrics and Gynecology, 225, 305.e1-305. https://doi.org/10.1016/j.ajog.2021.03.041
[17]
Duley, L., Hendersont, D. and Knight, M. (2001) Antiplatelet Drugs for Prevention of Pre-Eclampsia and Its Consequences, Systematic Review. British Medical Journal, 322, 329-333. https://doi.org/10.1136/bmj.322.7282.329
[18]
Farzaneh, F., Tavakolikia, Z. and Soleimanzadeh Mousavi, S.H. (2019) Assessment of Occurrence of Preeclampsia and Some Clinical and Demographic Risk Factors in Zahedan City in 2017. Clinical and Experimental Hypertension, 41, 583-588. https://doi.org/10.1080/10641963.2018.1523919
